SDZ.SW Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (17 geg. 2024 @ 18:30):

Stats
Dzisiejszy wolumen	1.17M
Średni wolumen	1.46M
Kapitalizacja rynkowa	13.75B
EPS	CHF0 ( 2023-09-30 )
Last Dividend	CHF0 ( N/A )
Next Dividend	CHF0 ( N/A )
P/E	199.94
ATR14	CHF0.0230 (0.07%)

Wolumen Korelacja

Długi: 0.08 (neutral)

Krótki: 0.68 (moderate)

Signal:(43.86) Neutral

Sandoz Group AG Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Sandoz Group AG Korelacja - Waluta/Towar

-0.33
( neutral )

-0.27
( neutral )

0.00
( neutral )

-0.31
( neutral )

0.55
( weak )

0.25
( neutral )

Sandoz Group AG Finanse

Annual	2023
Przychody:	CHF8.94B
Zysk brutto:	CHF4.07B (45.57 %)
EPS:	CHF0.160

FY	2023
Przychody:	CHF8.94B
Zysk brutto:	CHF4.07B (45.57 %)
EPS:	CHF0.160

FY	2022
Przychody:	CHF8.86B
Zysk brutto:	CHF4.15B (46.87 %)
EPS:	CHF-0.000100

Financial Reports:

No articles found.

Sandoz Group AG Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Sandoz Group AG

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. It develops, manufactures, and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services; and anti-infectives, such as active pharmaceutical ingredients and intermediates primarily antibiotics. The company was founded in 1886 and is headquartered in Rotkreuz, Switzerland.